Skip to main content

Umbilical Cord and Its Blood: A Perspective on Its Current and Potential Use in Ophthalmology

  • Chapter
  • First Online:
Regenerative Medicine Using Pregnancy-Specific Biological Substances
  • 773 Accesses

Abstract

Recently, umbilical cord blood has been used in the treatment of various ocular surface diseases in ophthalmology. Umbilical cord blood contains essential tear components, growth factors, and neurotrophic factors such as epidermal growth factor, vitamin A, transforming growth factor-b, substance P, insulin-like growth factor, and nerve growth factor. Umbilical cord serum can provide basic nutrients for epithelial renewal and facilitate the proliferation, migration, and differentiation of the ocular surface epithelium. Serum eye drops made from umbilical cord blood can be used safely and effectively for the treatment of severe dry eye with or without Sjögren’s syndrome, ocular complications in graft-versus-host disease, persistent epithelial defects, and neurotrophic keratopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Esquenazi S, He J, Bazab HEP, Bazan NG. Use of autologous serum in corneal epithelial defects post-lamellar surgery. Cornea. 2005;24:992-997.

    Article  PubMed  Google Scholar 

  2. Tsubota K, Higuchi A. Serum application for the treatment of ocular surface disorders. Int Ophthalmol Clin. 2000;40:113-122.

    Article  CAS  PubMed  Google Scholar 

  3. Fox RI, Chan R, Michelson JB, et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum. 1984;27:459-461.

    Article  CAS  PubMed  Google Scholar 

  4. Tsubota K, Goto E, Fujita H, et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome. Br J Ophthalmol. 1999;83:390-395.

    Article  CAS  PubMed  Google Scholar 

  5. Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatrical pemphigoid and Steven-Johnson syndrome. Am J Ophthalmol. 1996;122:38-52.

    CAS  PubMed  Google Scholar 

  6. Ogawa Y, Okamoto S, Mori T, et al. Autologous serum eyedrops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant. 2003;31:579-583.

    Article  CAS  PubMed  Google Scholar 

  7. Noble BA, Loh RS, MacLennan S, et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol. 2004;88:647-652.

    Article  CAS  PubMed  Google Scholar 

  8. Kojima T, Ishida R, Dogru M, et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol. 2005;139:242-246.

    Article  PubMed  Google Scholar 

  9. Tananuvat N, Daniell M, Suillivan LJ, et al. Controlled study of the use of autologous serum in dry eye patients. Cornea. 2001;20:802-806.

    Article  CAS  PubMed  Google Scholar 

  10. Tsubota K, Goto E, Shimmura S, et al. Treatment of ­persistent epithelial defect by autologous serum application. Ophthalmology. 1999;106:1984-1989.

    Article  CAS  PubMed  Google Scholar 

  11. Poon AC, Geerling G, Dart JK, et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol. 2001;85:1188-1197.

    Article  CAS  PubMed  Google Scholar 

  12. Young AL, Cheng AC, Ng HK, et al. The use of autologous serum tears in persistent epithelial defect. Eye. 2004;18:609-614.

    Article  CAS  PubMed  Google Scholar 

  13. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology. 2004;111:1115-1120.

    Article  PubMed  Google Scholar 

  14. Banker AS, Freeman WR, Azen SP, et al. A multicentered clinical study of serum as adjuvant therapy for surgical ­treatment of macular holes. Arch Ophthalmol. 1999;117:1499-1502.

    CAS  PubMed  Google Scholar 

  15. Goto E, Shimmura S, Shimazaki J, Tsubota K. Treatment of superior limbic keratoconjunctivitis by application of autologous serum. Cornea. 2001;20:807-810.

    Article  CAS  PubMed  Google Scholar 

  16. del Castillo JM, de la Casa JM, Sardina RC, et al. Treatment of recurrent corneal erosions using autologous serum. Cornea. 2002;21:781-783.

    Article  PubMed  Google Scholar 

  17. Schulze S, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol. 2006;142:207-211.

    Article  PubMed  Google Scholar 

  18. Matsuo H, Tomidokoro A, Tomita G, Araie M. Topical application of autologous serum for the treatment of late-onset aqueous oozing or point-leak through filtering bleb. Eye. 2005;19:23-28.

    Article  CAS  PubMed  Google Scholar 

  19. Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol. 2003;87:1312-1316.

    Article  CAS  PubMed  Google Scholar 

  20. Yoon KC, Heo H, Jeong IY, Park YG. Therapeutic effect of umbilical cord serum eydrops for persistent corneal epithelial defect. Korean J Ophthalmol. 2005;19:174-178.

    Article  PubMed  Google Scholar 

  21. Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea. 2006;25:268-272.

    Article  PubMed  Google Scholar 

  22. Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant. 2007;39:231-235.

    Article  CAS  PubMed  Google Scholar 

  23. Yoon KC, You IC, Im SK, et al. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology. 2007;114:1637-1642.

    Article  PubMed  Google Scholar 

  24. Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol. 2007;144:86-92.

    Article  PubMed  Google Scholar 

  25. Geerling G, MacLennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88:1467-1474.

    Article  CAS  PubMed  Google Scholar 

  26. Speek AJ, van Agtmaal EJ, Saowakontha S, et al. Fluorometric determination of retinol in human tear fluid using high-performance liquid chromatography. Curr Eye Res. 1986;5:841-845.

    Article  CAS  PubMed  Google Scholar 

  27. Ohashi Y, Motokura M, Kinoshita Y, et al. Presence of epidermal growth factor in human tears. Invest Ophthalmol Vis Sci. 1989;30:1879-1882.

    CAS  PubMed  Google Scholar 

  28. Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol. 2005;243:706-714.

    Article  CAS  PubMed  Google Scholar 

  29. Brown SM, Lamberts DW, Reid TW, et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor 1 [letter]. Arch Ophthalmol. 1997;115:926-927.

    CAS  PubMed  Google Scholar 

  30. Chikama T, Fukuda K, Morishige N, Nishida T. Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I [letter]. Lancet. 1998;351:1783-1784.

    Article  CAS  PubMed  Google Scholar 

  31. Tan MH, Bryars J, Moore J. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Cornea. 2006;25:352-355.

    Article  PubMed  Google Scholar 

  32. Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. New Eng J Med. 1998;338:1174-1180.

    Article  CAS  PubMed  Google Scholar 

  33. Leite SC, de Castro RS, Alves M, et al. Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation. Bone Marrow Transplant. 2006;38:223-227.

    Article  CAS  PubMed  Google Scholar 

  34. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109:235-242.

    Article  CAS  PubMed  Google Scholar 

  35. Choong PF, Mok PL, Cheong SK, Then KY. Mesenchymal stem cell-like characteristics of corneal keratocytes. Cytotherapy. 2007;9:252-258.

    Article  CAS  PubMed  Google Scholar 

  36. Kioke-Kiriyama N, Adachi Y, Minamino K, et al. Human cord blood cells can differentiate into retinal nerve cells. Acta Neurobiol Exp (Wars). 2007;67:359-365.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kyung-Chul Yoon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer London

About this chapter

Cite this chapter

Yoon, KC. (2011). Umbilical Cord and Its Blood: A Perspective on Its Current and Potential Use in Ophthalmology. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_18

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-718-9_18

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-717-2

  • Online ISBN: 978-1-84882-718-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics